Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis.

about

Cell apoptosis, autophagy and necroptosis in osteosarcoma treatment Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations.

P2860

Q28067107-FBAC3759-07D1-4E80-BBF7-3F031DD646AC Q52646480-A4B39868-71A4-4D46-A4EB-A3213C9E53E0

P2860

Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis.

Item

http://www.wikidata.org/entity/Q36750689

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis.

@en

type

Item

label

Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis.

@en

prefLabel

Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis.

@en

P1476

Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis.

@en

P2093

Alison Roos

http://www.w3.org/2001/XMLSchema#string

Daniel Fuja

http://www.w3.org/2001/XMLSchema#string

Jason T Yustein

http://www.w3.org/2001/XMLSchema#string

Laura Satterfield

http://www.w3.org/2001/XMLSchema#string

Lawrence A Donehower

http://www.w3.org/2001/XMLSchema#string

M John Hicks

http://www.w3.org/2001/XMLSchema#string

Ryan Shuck

http://www.w3.org/2001/XMLSchema#string

Shuying Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma

Emerging roles of caspase-3 in apoptosis

Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program

Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy.

Mechanisms of apoptosis by c-Myc.

Elevated expression of Runx2 as a key parameter in the etiology of osteosarcoma.

Caspase functions in cell death and disease.

Reaching a genetic and molecular understanding of skeletal development.

Osteosarcoma: a review of diagnosis, management, and treatment strategies.

Prognostic value of radiological response to chemotherapy in patients with osteosarcoma.

P2888

bjc.2015.305

P304

1289-1297

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2015.305

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26528706

http://www.w3.org/2001/XMLSchema#string

P932

4815801

http://www.w3.org/2001/XMLSchema#string

Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis.

about

P2860

P2860

Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P932